艾德韋宣(9919.HK)首日收報1.57港元 投資者關注高瓴入股消息
格隆匯1月16日丨奢侈品牌營銷服務龍頭艾德韋宣在今日(16日)正式登陸港股。此前,在招股期間,有消息透露高瓴資本參與了國際配售,高瓴資本為亞洲最大的投資機構之一,專注於長期結構性投資價值的公司,並在新經濟公司的投資中創下彪炳戰績,例如騰訊、百度、美團點評及百濟神州等,所以投資者一度對此反應熱烈。艾德韋宣在行業具有領導地位,特別是公司的IP業務前景廣闊,其擁有環法、西甲在中國舉辦授權活動的獨家權利,業務毛利率超過50%,部分市場分析人士預期艾德韋宣的IP業務有望帶領公司進入持續增長的通道。艾德韋宣上市首日收報1.57港元,成交金額2.96億港元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.